AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. EBITDA margin (%)

KISSEI PHARMACEUTICAL CO.,LTD.【JP:4547】

Market cap
¥229.5B
P/E ratio
15.7x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Mar 31, 202511.8+7.46%
Mar 31, 202410.9+147.86%
Mar 31, 20234.4+24.00%
Mar 31, 20223.6-47.16%
Mar 31, 20216.7-3.57%
Mar 31, 20207-42.65%
Mar 31, 201912.2-27.15%
Mar 31, 201816.7+10.43%
Mar 31, 201715.1-14.41%
Mar 31, 201617.7+17.75%
Mar 31, 201515

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)